|
1
|
Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.
|
Leukemia
|
2005
|
1.39
|
|
2
|
Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome.
|
Leukemia
|
2011
|
0.99
|
|
3
|
Loss of tumorigenicity of murine colon carcinoma MC38/0 cell line after transduction with a retroviral vector carrying murine IL-12 genes.
|
Folia Biol (Praha)
|
2004
|
0.84
|
|
4
|
Preliminary results of HBV DNA testing of Polish haemophilia patients--lack of occult HBV infection.
|
Haemophilia
|
2006
|
0.78
|
|
5
|
Recent developments in retroviral gene delivery systems.
|
Expert Opin Biol Ther
|
2001
|
0.76
|
|
6
|
Genetically modified dendritic cells--a new, promising cancer treatment strategy?
|
Expert Opin Biol Ther
|
2002
|
0.76
|
|
7
|
Thymus-directed immunotoxicity of airborne dust particles from Upper Silesia (Poland) under acute extrapulmonary studies in mice.
|
J Toxicol Environ Health
|
1996
|
0.76
|
|
8
|
Prevalence of human parvovirus B19 DNA and IgG/IgM antibodies in Polish haemophilia patients.
|
Vox Sang
|
1999
|
0.76
|
|
9
|
Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation.
|
Transpl Infect Dis
|
2007
|
0.75
|
|
10
|
Analysis of hepatitis G virus infection markers in blood donors and patients with hepatitis.
|
J Viral Hepat
|
1999
|
0.75
|
|
11
|
[Diagnosis of human parvovirus B19 infection in nonimmune hydrops fetalis].
|
Ginekol Pol
|
1998
|
0.75
|
|
12
|
Humoral responses to melanoma vaccine, genetically modified with interleukin 6 and soluble interleukin 6 receptor.
|
Adv Exp Med Biol
|
2001
|
0.75
|
|
13
|
The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland.
|
Transfusion
|
2004
|
0.75
|
|
14
|
IL-6 and GM-CSF in tumor rejection model of renal cell cancer.
|
Adv Exp Med Biol
|
2001
|
0.75
|
|
15
|
Flow cytometric cytotoxicity assay with GFP gene modified target cells.
|
Adv Exp Med Biol
|
2001
|
0.75
|
|
16
|
Anti-HCV RIBA/LiaTek reactivity and HCV genotype in EIA-negative patients with viremia.
|
J Med Virol
|
1999
|
0.75
|